YishengBio

Business Model
B2B
Last Round
Series BMar 2021
Rounds
1

About

YishengBio (YS Biopharma) is a biopharmaceutical company developing vaccines and therapeutic biologics, with operations in both China and the United States.

Summary

YishengBio is a Biotech company based in Gaithersburg, United States. Its most recent funding was a Series B round in Mar 2021. Investors include OrbiMed, Oceanpine Capital and F-Prime Capital.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series BSeries BMar 2021

Investors

Similar Companies